ConductScience.org, home

Paper · 42640583

Single-Cell Glycomics of the Pancreatic Tumor Microenvironment: Technologies, Glyco-Immune Checkpoints, and Tumor-Immune Communication.

Anh DXT and 1 other. Adv Biol (Weinh), 2026. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Single-Cell Glycomics of the Pancreatic Tumor Microenvironment: Technologies, Glyco-Immune Checkpoints, and Tumor-Immune Communication. Papers, record 42640583. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42640583

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Single-Cell Glycomics of the Pancreatic Tumor Microenvironment: Technologies, Glyco-Immune Checkpoints, and Tumor-Immune Communication.
PubMed
Journal
Adv Biol (Weinh)
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-27
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Anh DXTDinh Xuan Tuanhttps://orcid.org/0009-0003-6126-6259
2Tateno HHiroakihttps://orcid.org/0000-0003-3006-1659

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlycomicsMajor topic
Tumor MicroenvironmentMajor topic
Pancreatic NeoplasmsMajor topic
Single-Cell AnalysisMajor topic
Carcinoma, Pancreatic DuctalMajor topic
Humans
Polysaccharides
Epithelial-Mesenchymal Transition
Animals
Cell Communication

Source PubMed

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
23K26872Takeda COCKPI-T Funding, JSPS KAKENPubMed
23H04796Takeda COCKPI-T Funding, JSPS KAKENPubMed
26K21874Takeda COCKPI-T Funding, JSPS KAKENPubMed
JPMJNX26B3JST NEXUSPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References123

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131,389,667Truncated O-glycans promote epithelial-to-mesenchymal transition and stemness properties of pancreatic cancer cells.J Cell Mol Med2019https://conductscience.org/library/papers/31389667PubMed
233,067,390Mapping glycan-mediated galectin-3 interactions by live cell proximity labeling.Proc Natl Acad Sci U S A2020https://conductscience.org/library/papers/33067390PubMed
341,380,686Single-cell glycome and transcriptome profiling enabled by a library of anti-glycan antibodies.Cell Chem Biol2025https://conductscience.org/library/papers/41380686PubMed
437,166,286Single-Cell Glycan and RNA Sequencing (scGR-seq).Curr Protoc2023https://conductscience.org/library/papers/37166286PubMed
540,381,815Sialyltransferase ST3GAL4 directs a dual mechanism to promote pancreatic ductal adenocarcinoma progression by regulating endoplasmic reticulum stress and mitochondrial homeostasis.Biochim Biophys Acta Mol Basis Dis2025https://conductscience.org/library/papers/40381815PubMed
61,710,913Detection of antigen-antibody interactions by surface plasmon resonance. Application to epitope mapping.J Mol Recognit1990https://conductscience.org/library/papers/1710913PubMed
738,535,625Targeted and Self-Adjuvated Nanoglycovaccine Candidate for Cancer Immunotherapy.ACS Nano2024https://conductscience.org/library/papers/38535625PubMed
840,399,501Identification of CLEC10A as a human lectin for pancreatic ductal adenocarcinoma.Sci Rep2025https://conductscience.org/library/papers/40399501PubMed
919,714,693Bioorthogonal chemistry: fishing for selectivity in a sea of functionality.Angew Chem Int Ed Engl2009https://conductscience.org/library/papers/19714693PubMed
1040,017,017The Impact of the Mass Analyzer and Tissue Section Thickness on Spatial N-Glycomics with MALDI-MSI.J Am Soc Mass Spectrom2025https://conductscience.org/library/papers/40017017PubMed

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42,925,266scGlycoAI: machine learning analysis of single-cell glycan and RNA sequencing data for cell-type annotation and malignancy-associated glycan discovery.Glycobiology2026https://conductscience.org/library/papers/42925266

Source PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42640583

GET https://conductscience.org/api/papers/v1/42640583/references?page=2